NCT05016830

Brief Summary

A prospective interventional study is expected to be conducted, to test a possible new treatment for amblyopia (lazy eye syndrome). Bilateral transcranial direct current stimulation (tDCS) is a type of noninvasive brain stimulation, which may help in visual function recovery of adult patients with amblyopia. This pilot study will test the feasibility of said therapy, along with the short term effects of bilateral tDCS in visual function.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 5, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

August 13, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 23, 2021

Completed
Last Updated

August 23, 2021

Status Verified

August 1, 2021

Enrollment Period

3 months

First QC Date

August 13, 2021

Last Update Submit

August 20, 2021

Conditions

Keywords

Lazy eye syndromeTranscranial direct current stimulationOcular occlusionAmblyopia

Outcome Measures

Primary Outcomes (4)

  • Visual Acuity

    Clarity or Sharpness in vision, measured in LogMar

    1-2 hours

  • Visual Sensitivity

    The ability to perceive differences between an object and its background, measured in percentage of contrast sensitivity.

    1-2 hours

  • Stereopsis

    the perception of depth produced by the reception in the brain of visual stimuli from both eyes in combination. Measured in degrees of arc.

    1-2 hours

  • Visual evoked potentials

    The electroencephalographic response from the primary visual cortex to a stimuli. Measured in millivolts (mV).

    1-2 hours

Study Arms (2)

Sham bilateral transcranial direct current stimulation

SHAM COMPARATOR

Sham bilateral transcranial direct current stimulation consisted of 2 milliamperes (mA) of current from the anodal electrode in the amblyopic primary visual cortex to the cathodal electrode located in the fellow primary visual cortex, but the stimulation was turned off after 30 seconds. On Sham Stimulation onset, the participant's fellow eye was occluded and the participant performed a reading task for 20 minutes.

Device: Bilateral transcranial direct current stimulation

Bilateral transcranial direct current stimulation

EXPERIMENTAL

Bilateral transcranial direct current stimulation consisted of 2 mA of current from the anodal electrode in the amblyopic primary visual cortex to the cathodal electrode located in the fellow primary visual cortex and the stimulation was on for 20 minutes. On stimulation onset, the participant's fellow eye was occluded and the participant performed a reading task for 20 minutes.

Device: Bilateral transcranial direct current stimulation

Interventions

A direct current is applied with two electrodes (cathode and anode) in specific parts of the skull. In this case the anode was over the occipital area to target the amblyopic cortex, while the cathode was over the contralateral side, targeting the fellow cortex.

Bilateral transcranial direct current stimulationSham bilateral transcranial direct current stimulation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Prior diagnosis of Amblyopia

You may not qualify if:

  • Ophthalmologic disease other than amblyopia
  • Chronic pharmacological therapy
  • Implanted medical device
  • Neurologic disease or surgery history
  • History of an adverse reaction to tDCS
  • Pregnancy
  • Not able to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine of University of Chile

Santiago, Santiago Metropolitan, 8380453, Chile

Location

MeSH Terms

Conditions

Amblyopia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Romulo A Fuentes Flores, PhD

    University of Chile

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Both sham and bilateral transcranial direct current stimulation were applied with the same electrode configuration, but the functioning of the stimulation device was blinded to the patient, the care provider, and the researcher performing measurements. The operator of the stimulation device selected the stimulation protocol. Sham stimulation protocol consisted of current ramp and delivery of current for 30 seconds and 19 minutes and 30 seconds with no current delivery. Actual stimulation consisted of a current ramp and 20 minutes of current delivery. There were no visual cues allowing to differentiate sham and stimulation protocols.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized, controlled pilot trial, that consists in two groups: a control group that receives sham stimulation and ocular occlusion, and a second group that receives bilateral transcranial direct current stimulation and ocular occlusion.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor at Department of Neuroscience, and Director of Research at the Faculty of Medicine of University of Chile

Study Record Dates

First Submitted

August 13, 2021

First Posted

August 23, 2021

Study Start

November 5, 2019

Primary Completion

January 31, 2020

Study Completion

January 31, 2020

Last Updated

August 23, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations